Three Success Factors To Accelerate Your Program To Clinical Trial

By Jennifer DePolo, President, General Manager and Site Head of the Siegfried Acceleration Hub

Bringing a promising molecule to the clinic requires more than speed. It demands informed decisions early in development. With fewer than one in ten drug candidates ultimately reaching commercialization, early-phase strategy can have a significant impact on cost, timelines, and program success.

Three factors play a critical role in accelerating clinical readiness: asking the right scientific and CMC questions from the outset, making phase-appropriate development decisions, and planning for scalability long before commercial manufacturing becomes a priority. Early attention to formulation challenges, manufacturability, supply strategy, and future regulatory requirements can help reduce risk, minimize wasted resources, and support faster progression toward clinical milestones.

Discover practical approaches to prioritizing development activities, maximizing limited materials and budgets, and building a foundation for long-term success. Access the full webinar to learn how experienced development teams accelerate programs while maintaining flexibility for future growth.